SCR 20: Peripartum Cardiomyopathy Awareness Month.
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2025-03-25
Current Status:
Passed
(2025-03-25: Chaptered by Secretary of State. Res. Chapter 27, Statutes of 2025.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
This measure would designate February 2025 as Peripartum Cardiomyopathy Awareness Month.
This measure would designate February 2025 as Peripartum Cardiomyopathy Awareness Month.
This measure would designate February 2025 as Peripartum Cardiomyopathy Awareness Month.
WHEREAS, Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period; and
WHEREAS, According to the New England Journal of Medicine, the incidence of PPCM varies from 1 in 100 to 1 in 300 pregnancies in geographic hot spots, such as Nigeria and Haiti, to 1 in 1,000 to 1 in 4,000 in Europe and the United States; and
WHEREAS, According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between 2017 and 2019, inclusive; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found; and
WHEREAS, PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs; and
WHEREAS, PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness; and
WHEREAS, A weight gain of three pounds or more over a day or two may signal a fluid buildup that warrants a conversation with a medical professional; and
WHEREAS, Several factors increase the risk of developing PPCM, including high blood pressure, preeclampsia, multiple gestations (e.g., twins), and advanced maternal age (e.g., 35 years of age or older); and
WHEREAS, PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies; and
WHEREAS, According to the New England Journal of Medicine, some genetic mutationsincluding titin truncating variantsmay predispose some women to PPCM; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed when three criteria are met: 1) heart failure develops in late pregnancy or within months following delivery; 2) left ventricular ejection fraction (the percentage of fluid ejected from the left ventricle) is less than 45 percent (typically measured by an echocardiogram); and 3) no other cause for this heart failure can be found; and
WHEREAS, Brain natriuretic peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) levels may be tested to indicate to medical providers that the heart is not pumping properly; and
WHEREAS, If caught early, many women with PPCM will recover normal heart function within six months after treatment starts; and
WHEREAS, If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death; and
WHEREAS, PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt; and
WHEREAS, Women can minimize their PPCM risk by not drinking or smoking, eating a well-balanced diet, exercising, and monitoring their blood pressure; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period; and
WHEREAS, According to the New England Journal of Medicine, the incidence of PPCM varies from 1 in 100 to 1 in 300 pregnancies in geographic hot spots, such as Nigeria and Haiti, to 1 in 1,000 to 1 in 4,000 in Europe and the United States; and
WHEREAS, According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between 2017 and 2019, inclusive; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found; and
WHEREAS, PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs; and
WHEREAS, PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness; and
WHEREAS, A weight gain of three pounds or more over a day or two may signal a fluid buildup that warrants a conversation with a medical professional; and
WHEREAS, Several factors increase the risk of developing PPCM, including high blood pressure, preeclampsia, multiple gestations (e.g., twins), and advanced maternal age (e.g., 35 years of age or older); and
WHEREAS, PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies; and
WHEREAS, According to the New England Journal of Medicine, some genetic mutationsincluding titin truncating variantsmay predispose some women to PPCM; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed when three criteria are met: 1) heart failure develops in late pregnancy or within months following delivery; 2) left ventricular ejection fraction (the percentage of fluid ejected from the left ventricle) is less than 45 percent (typically measured by an echocardiogram); and 3) no other cause for this heart failure can be found; and
WHEREAS, Brain natriuretic peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) levels may be tested to indicate to medical providers that the heart is not pumping properly; and
WHEREAS, If caught early, many women with PPCM will recover normal heart function within six months after treatment starts; and
WHEREAS, If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death; and
WHEREAS, PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt; and
WHEREAS, Women can minimize their PPCM risk by not drinking or smoking, eating a well-balanced diet, exercising, and monitoring their blood pressure; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period; and
WHEREAS, According to the New England Journal of Medicine, the incidence of PPCM varies from 1 in 100 to 1 in 300 pregnancies in geographic hot spots, such as Nigeria and Haiti, to 1 in 1,000 to 1 in 4,000 in Europe and the United States; and
WHEREAS, According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between 2017 and 2019, inclusive; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found; and
WHEREAS, PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs; and
WHEREAS, PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness; and
WHEREAS, A weight gain of three pounds or more over a day or two may signal a fluid buildup that warrants a conversation with a medical professional; and
WHEREAS, Several factors increase the risk of developing PPCM, including high blood pressure, preeclampsia, multiple gestations (e.g., twins), and advanced maternal age (e.g., 35 years of age or older); and
WHEREAS, PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies; and
WHEREAS, According to the New England Journal of Medicine, some genetic mutationsincluding titin truncating variantsmay predispose some women to PPCM; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed when three criteria are met: 1) heart failure develops in late pregnancy or within months following delivery; 2) left ventricular ejection fraction (the percentage of fluid ejected from the left ventricle) is less than 45 percent (typically measured by an echocardiogram); and 3) no other cause for this heart failure can be found; and
WHEREAS, Brain natriuretic peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) levels may be tested to indicate to medical providers that the heart is not pumping properly; and
WHEREAS, If caught early, many women with PPCM will recover normal heart function within six months after treatment starts; and
WHEREAS, If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death; and
WHEREAS, PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt; and
WHEREAS, Women can minimize their PPCM risk by not drinking or smoking, eating a well-balanced diet, exercising, and monitoring their blood pressure; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Mar 25, 2025 | Chaptered by Secretary of State. Res. Chapter 27, Statutes of 2025. |
| Mar 25, 2025 | Enrolled and filed with the Secretary of State at 2 p.m. |
| Mar 20, 2025 | In Senate. Ordered to engrossing and enrolling. |
| Mar 20, 2025 | Read. Adopted. (Ayes 67. Noes 0. Page 774.) Ordered to the Senate. |
| Mar 17, 2025 | From committee: Be adopted. Ordered to consent calendar. (Ayes 10. Noes 0.) (March 17). |
| Mar 3, 2025 | Referred to Com. on RLS. |
| Feb 27, 2025 | In Assembly. Held at Desk. |
| Feb 27, 2025 | Read. Adopted. (Ayes 35. Noes 0. Page 286.) Ordered to the Assembly. |
| Feb 19, 2025 | From committee: Ordered to third reading. |
| Feb 10, 2025 | Introduced. Referred to Com. on RLS. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Mar 20, 2025 | SCR 20 Ochoa Bogh Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Mar 17, 2025 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
|
| Feb 27, 2025 | Senate 3rd Reading SCR20 Ochoa Bogh et al. | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: March 17, 2025
ASSEMBLY COMMITTEE ON RULES
Blanca Pacheco, Chair
SBPCA Bill Id:SCR 20
Author:(Ochoa Bogh) – As Introduced Ver:
SENATE VOTE:
SUBJECT: Peripartum Cardiomyopathy Awareness Month.
SUMMARY: Proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month. Specifically, this resolution makes the following legislative findings:
- Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period.
- According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between 2017 and 2019, inclusive.
- According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found. PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs.
- PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies.
- If caught early, many women with PPCM will recover normal heart function within six months after treatment starts. If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death.
- PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt.
FISCAL EFFECT: This resolution is keyed non-fiscal by Legislative Counsel.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SCR 20 |
THIRD READING
Bill No: SCR 20
Author: Ochoa Bogh (R), et al.
Introduced: 2/10/25
Vote: 21
SUBJECT: Peripartum Cardiomyopathy Awareness Month
SOURCE: Author
DIGEST:
This resolution designates February 2025 as Peripartum Cardiomyopathy Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period.
- According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9% of pregnancy-related deaths between 2017 and 2019, inclusive.
- PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness.
- If caught early, many women with PPCM will recover normal heart function within six months after treatment starts. If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death.
This resolution proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 2/18/25)
None received
OPPOSITION: (Verified 2/18/25)
None received
Prepared by: Hunter Flynn / SFA / (916) 651-1520
2/19/25 16:01:04
**** END ****
Bill Author
Bill Co-Author(s):